Sleep Experts: Melatonin, Sex, and their impact on Sleep w/ Arianna Huffington & Matt Walker | #168
A live Q&A from the 2025 Abundance Summit where Peter Diamandis moderates audience questions for Arianna Huffington and sleep scientist Matt Walker. Topics range from sleep supplements, restless leg syndrome, and a detailed jet-lag protocol to melatonin's real risks (especially for kids), modafinil use, individual variability in sleep need, and sex's measurable effect on sleep quality. Walker also reveals his company just raised funding and is starting a clinical trial for a new compound meant to protect against the consequences of insufficient sleep. Huffington repeatedly reframes the conversation around stress management, boundary-setting, and treating wellbeing as more than a number on a wearable.
Matt Walker recommends phosphatidylserine and ashwagandha (300-400mg) with 2-3g glycine to calm the fight-or-flight response and lower cortisol for 'tired but wired' insomnia.
Restless leg syndrome treatment pathwayHealth▶ 5:30
Walker describes RLS as commonly misdiagnosed and lays out a three-tier medication escalation from gabapentin/pregabalin to dopamine agonists to opioid-like drugs.
Managing stress and geopolitical anxiety at nightHealth▶ 8:27
Huffington advises cutting off news consumption at a set time and disabling all notifications except from people you love, since most 'breaking news' alerts aren't urgent.
Walker gives a step-by-step jet-lag routine: switch your watch to destination time immediately, avoid alcohol/caffeine in flight, build sustained wakefulness, get morning daylight, and time melatonin and a hot bath before bed.
Melatonin dosing, quality, and pediatric riskHealth▶ 13:53
Walker warns most people overdose melatonin, supplement labels are wildly inaccurate, and giving melatonin to children risks disrupting gonadal development based on rat studies.
Modafinil as an occasional wakefulness aidHealth▶ 15:59
Walker says modafinil lacks long-term weekly-use safety data and should be reserved for rare 'break glass' situations due to addictive potential.
An audience member describes thriving on a consistent midnight-to-6am schedule despite heavy travel; Walker says wearable stress proxies aren't enough and recommends blood-panel validation, while noting essentially 0% of people function on under 7 hours without measurable impairment.
Walker cites data that orgasm improves subjective sleep quality by 70-73% (solo masturbation ~50%), and that an extra hour of sleep raises a woman's intimacy interest more than a libido drug does.
Huffington frames behavior change as 'a miracle drug' and promotes being the CEO of your own health, tying it to her foundation's nonprofit and workplace outreach work.
Predictions made
openMatt Walker: Walker's company will move into clinical trials for a new pharmacological compound designed to protect against the health consequences of insufficient sleep, following a newly closed funding round.
“we've just raised a round of funding and we are about to start the clinical trial with a new pharmacological suite of compounds that will protect you”
Your call:
Numbers that matter
300-400mg phosphatidylserine/ashwagandha plus 2-3g glycineMatt Walker's typical client dosing to calm fight-or-flight and lower cortisol for insomnia tied to stress.
3mg melatonin 45 minutes before bed; 10-12 hours sustained wakefulness; 20 minutes of daylight in first two hoursCore numbers in Walker's jet-lag protocol.
1-3mg normative melatonin dose vs. 5-20mg commonly takenWalker's case that most people take a 'super physiological' overdose of melatonin.
Melatonin supplement content ranged from 83% less to 464% more than labeled across 20 vendorsCited study on supplement label accuracy.
0% of the population shows no impairment on under 7 hours of sleepWalker's data-based rebuttal to claims of thriving on short sleep.
Orgasm improves subjective sleep quality by 70-73%; masturbation achieves about 50% of that effectWalker's data on sex and sleep quality.
+1 hour of sleep raises a woman's intimacy interest by ~14%, vs. ~24% from prescription libido drugsComparing sleep's effect on libido to pharmaceutical libido drugs.
Worth digging into
🕳️ Matt Walker's new sleep-protection compound
A funded, clinical-stage drug meant to protect against the consequences of sleep loss (not just induce more sleep) could be a meaningful travel/shift-work product if it pans out.
🕳️ Melatonin label-accuracy study
A 20-vendor study finding melatonin content from 83% below to 464% above the labeled dose is a serious supplement-safety and regulatory gap most parents don't know about.
🕳️ Melatonin and pediatric gonadal development
Nightly melatonin use in kids is now common, but Walker cites a juvenile rat study showing testicular atrophy from high doses, which directly contradicts casual pediatric use.
🕳️ Sleep duration vs. libido drugs
The claim that one extra hour of sleep produces more of the benefit than an approved prescription libido drug is a striking comparison worth sourcing.
🕳️ Restless leg syndrome underdiagnosis
Walker calls RLS one of the most misdiagnosed sleep disorders despite a well-defined three-tier drug pathway, suggesting a gap between known treatment and real-world diagnosis rates.